Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months

Kenji Inoue1 Inouye Eye Hospital, Tokyo, JapanCorrespondence[email protected]

Ryoko Okayama1 Inouye Eye Hospital, Tokyo, Japan

Risako Higa1 Inouye Eye Hospital, Tokyo, Japan

Goji Tomita2 Second Department of Ophthalmology, Toho University School of Medicine, Tokyo, Japan

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kenji Inoue, Taku Kawashima, Seiki Katakura, Kyoko Shidara, Takayuki Fujimoto, Hiromi Kohmoto, Minako Shiokawa, Ryo Moriyama & Ryoko Okayama. (2018) Switching from concomitant therapy to tafluprost/timolol fixed combination. Clinical Ophthalmology 12, pages 549-554.
Read now

Articles from other publishers (1)

Kenji Inoue, Shiho Kunimatsu-Sanuki, Kyoko Ishida & Goji Tomita. (2022) Intraocular pressure-lowering effects and safety of brimonidine/brinzolamide fixed combination after switching from other medications. Japanese Journal of Ophthalmology 66:5, pages 440-446.
Crossref

Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months

Articles from other publishers (1)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months

Citations (2)

Read on this site (1)

Articles from other publishers (1)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date